Simplex Trading
PAVM icon

Simplex Trading’s PAVmed PAVM Stock Holding History

Simplex Trading’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-67
Closed -$1K – 9288
2024
Q2 		$1K Sell
67
-3
-4% -$150 ﹤0.01% 8522
2024
Q1 		$4K Buy
+70
New +$5.29K ﹤0.01% 8148
2023
Q4 		– Sell
-21
Closed -$2K – 9552
2023
Q3 		$2K Hold
21
– – ﹤0.01% 8140
2023
Q2 		$3K Hold
21
– – ﹤0.01% 8258
2023
Q1 		$3K Sell
21
-37
-64% -$7.79K ﹤0.01% 8335
2022
Q4 		$12K Sell
58
-21
-27% -$7.93K ﹤0.01% 7380
2022
Q3 		$30K Buy
79
+66
+508% +$37.4K ﹤0.01% 7082
2022
Q2 		$5K Hold
13
– – ﹤0.01% 8850
2022
Q1 		$7K Sell
13
-57
-81% -$42.4K ﹤0.01% 9189
2021
Q4 		$77K Buy
70
+1
+1% +$2.17K ﹤0.01% 6640
2021
Q3 		$195K Hold
69
– – ﹤0.01% 5625
2021
Q2 		$199K Buy
69
+67
+3,350% +$158K ﹤0.01% 5687
2021
Q1 		$345K Buy
+2
New +$3.01K ﹤0.01% 3953

Other funds holding PAVM

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Simplex Trading's PAVM Position: Q1 2026 in Review

Simplex Trading sold out of PAVmed (PAVM) in Q1 2026, closing a stake of 35 shares — an estimated $231 sold.

Simplex Trading first reported a position in PAVM in Q1 2021 and held it in 15 quarters. The position peaked at $85K in Q4 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

  • Simplex Trading reported no remaining PAVmed position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 35 PAVmed shares in Q1 2026, an estimated $231.
  • Simplex Trading first reported a position in PAVmed in Q1 2021 and held it in 15 quarters.
  • Simplex Trading's PAVmed position peaked at $85K in Q4 2021.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.